Craniopharyngioma – a chronic disease

As surgical expertise has a proven impact on post-treatment morbidity, medical societies should establish criteria of adequate professional expertise for surgical treatment of craniopharyngioma.

Diet, medication use and drug intake during pregnancy: data from the Swiss Health Surveys 2007 and 2012

Adoption of a healthy lifestyle during pregnancy should remain a basic aim of national policies for health promotion and prevention of unexpected pregnancy outcomes.

Aortic valve replacement using autologous pericardium: single centre experience with the Ozaki technique

The Ozaki procedure for aortic valve replacement involves reconstructing the valve leaflets from autologous pericardium. Potential benefits include avoidance of oral anticoagulation and suitability for patients with small aortic annuli.

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry

There is no definitive treatment for primary Sjögren’s syndrome, but several clinical trials are ongoing or planned. The disease activity indexes (ESSDAI and ClinESSDAI) are used to assess eligibility and outcomes in clinical trials.

A ten-year follow-up study of treatment outcome of craniopharyngiomas

Craniopharyngioma-related hypothalamic obesity is a devastating complication. There is limited data on whether long-term follow-up of craniopharyngioma patients should focus on problems other than endocrine deficiencies and weight gain.

The influence of hospitalisation on the initiation, continuation and discontinuation of benzodiazepines and Z-drugs – an observational study

A few studies have explored changes in benzodiazepine or sleep medication use as a function of hospitalisation, but failed to precisely determine the hospital’s role in initiating, continuing and discontinuing these drugs.